ScienceMore in Science→
Scientists Identify Critical Drug Target for 'Brain on Fire' Autoimmune Disease
Key Takeaways
- Scientists identified how antibodies trigger NMDA receptor internalization in 'Brain on Fire' disease
- Discovery reveals specific molecular targets for new drugs
- Current treatments broadly suppress the immune system with significant side effects
- A targeted therapy could block the disease mechanism without compromising immunity
- The condition predominantly strikes young adults and children, often mimicking psychiatric illness
DE
DT Editorial Team··4 min read·via sciencedaily.com